Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

373 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Coronary plaque phenotype associated with positive remodeling.
Kinoshita D, Suzuki K, Yuki H, Niida T, Fujimoto D, Minami Y, Dey D, Lee H, McNulty I, Ako J, Ferencik M, Kakuta T, Ye JC, Jang IK. Kinoshita D, et al. Among authors: fujimoto d. J Cardiovasc Comput Tomogr. 2024 Jul-Aug;18(4):401-407. doi: 10.1016/j.jcct.2024.04.009. Epub 2024 Apr 26. J Cardiovasc Comput Tomogr. 2024. PMID: 38677958
Relationship between plaque burden and plaque vulnerability: Acute coronary syndromes versus chronic coronary syndrome.
Kinoshita D, Suzuki K, Fujimoto D, Niida T, Usui E, Minami Y, Dey D, Lee H, McNulty I, Ako J, Ferencik M, Kakuta T, Jang IK. Kinoshita D, et al. Among authors: fujimoto d. J Cardiovasc Comput Tomogr. 2024 Sep 14:S1934-5925(24)00436-2. doi: 10.1016/j.jcct.2024.09.002. Online ahead of print. J Cardiovasc Comput Tomogr. 2024. PMID: 39278792
Differences in total plaque burden between plaque rupture and plaque erosion: A combined computed tomography angiography and optical coherence tomography study.
Niida T, Usui E, Suzuki K, Kinoshita D, Yuki H, Fujimoto D, Covani M, Dey D, Lee H, McNulty I, Ferencik M, Yonetsu T, Kakuta T, Jang IK. Niida T, et al. Among authors: fujimoto d. J Cardiovasc Comput Tomogr. 2024 Sep 24:S1934-5925(24)00441-6. doi: 10.1016/j.jcct.2024.09.007. Online ahead of print. J Cardiovasc Comput Tomogr. 2024. PMID: 39322513
Reply to a letter.
Fujimoto D, Obata N, Mizobuchi S. Fujimoto D, et al. J Anesth. 2024 Nov 4. doi: 10.1007/s00540-024-03426-1. Online ahead of print. J Anesth. 2024. PMID: 39495289 No abstract available.
YAP regulates HER3 signaling-driven adaptive resistance to RET inhibitors in RET-aberrant cancer.
Katayama Y, Yamada T, Tanimura K, Kawachi H, Ishida M, Matsui Y, Hirai S, Nakamura R, Morimoto K, Furuya N, Arai S, Goto Y, Sakata Y, Nishino K, Tsuchiya M, Tamiya A, Saito G, Muto S, Takeda T, Date K, Fujisaka Y, Watanabe S, Fujimoto D, Uehara H, Horinaka M, Sakai T, Yano S, Tokuda S, Takayama K. Katayama Y, et al. Among authors: fujimoto d. Clin Cancer Res. 2024 Nov 4. doi: 10.1158/1078-0432.CCR-24-1762. Online ahead of print. Clin Cancer Res. 2024. PMID: 39495173
Durvalumab with etoposide and carboplatin for patients with extensive-stage small cell lung cancer and interstitial lung disease: A multicenter, open-label prospective trial.
Shibaki R, Fujimoto D, Miyauchi E, Tsukita Y, Nakachi I, Arai D, Sakata Y, Shingu N, Shimokawa T, Kijima T, Tamiya M, Kawana S, Hara S, Saito G, Sato Y, Yokoyama T, Sakata S, Taniguchi Y, Hata A, Matsumoto H, Yamaguchi T, Yamamoto N. Shibaki R, et al. Among authors: fujimoto d. Lung Cancer. 2024 Oct;196:107958. doi: 10.1016/j.lungcan.2024.107958. Epub 2024 Sep 19. Lung Cancer. 2024. PMID: 39312871 Clinical Trial.
373 results